DigestRedComo funciona
Red
/
Empresas
Bo
No verificado

Boehringer Ingelheim

Sobre qué escribimos

EmpresasFarmacéuticaIndustriaMedicina Salud BienestarPublicidad/Marketing/Medios de comunicación/Comunicación

7 Comunicados de prensa

Ver todos los comunicados de prensa
16/09/2026
Farmacéutica
Medicina Salud Bienestar
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
Fuente
Boehringer Ingelheim
Editor
GLOBENEWSWIRE
1.00
0
11/08/2026
Farmacéutica
Medicina Salud Bienestar
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
Fuente
Boehringer Ingelheim
Editor
GLOBENEWSWIRE
1.00
0
15/07/2026
Farmacéutica
Medicina Salud Bienestar
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
Fuente
Boehringer Ingelheim
Editor
GLOBENEWSWIRE
1.00
0
03/09/2025
Boehringer Ingelheim Launches Swine Vaccine With Advanced Protection Against Porcine Circovirus Type 2 in the United States
Fuente
Boehringer Ingelheim
Editor
Business Wire
1.00
0
Press Release cover image
22/11/2024
Farmacéutica
Sanidad
Economía
Start-up
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
Fuente
Boehringer Ingelheim
Editor
PR News Wire
1.00
0
07/10/2024
Farmacéutica
Medicina Salud Bienestar
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
Fuente
Boehringer Ingelheim
Editor
GLOBENEWSWIRE
1.00
0
16/09/2024
Farmacéutica
Medicina Salud Bienestar
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Fuente
Boehringer Ingelheim
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0